ArticleFrontiers in plant science2025
The CRY1-HsF predicted interaction interface serves as a molecular platform for bioengineering or selecting modulating mutants.
Article in Frontiers in plant science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Structure-guided optimization of SLY1 expression and purification in Escherichia coli.Protein science : a publication of the Protein Society · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: High-temperature stress imposes an energetic cost on plant growth and negatively impacts agricultural productivity. This stress rapidly triggers the activation of Heat shock Factor (HsF) proteins, a family of transcription factors that maintain proteostasis. The cryptochrome CRY1 can physically interact with HsFA1d proteins to facilitate nucleus translocation and the regulation of genes that contributes to stress tolerance. Methods: We combined structural predictions with experimental testing using yeast-two-hybrid and bimolecular fluorescence complementation assays. Results: We confirm that CRY1 PHR domain interacts extensively with multiple HsF proteins through their HR-A region of the conserved oligomerization HR-A/B domain interface. This interaction partially relies on salt bridges provided by the N- and C-terminus of HR-A region and a conserved interface centered around W352 of CRY1. HsFA3 shows the strongest affinity to CRY1 in yeast-two-hybrid assays notably thanks to a glutamate residue that interacts with R211 and R435 of CRY1. Mutating equivalent residue positions within HsFA1e or HsFC1 to a glutamate increased their interaction to CRY1. Discussion: Overall, our analysis allowed the identification of mutant candidate that could be used in selection or bioengineering endeavors to improve thermal stress tolerance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.